Should you buy The Procter & Gamble stock now?
The technical signal for The Procter & Gamble is currently NEUTRAL. The Procter & Gamble trades at $146.88 as of 8/6/2026. The overall technical signal is: Hold. The technical analysis shows the following: MACD is negative (bearish trend) at -0.222 with falling momentum (signal: -0.070); RSI is at 49.8 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $160.70 points to 9.4% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for The Procter & Gamble stock?
The average analyst price target for The Procter & Gamble is $160.70. The current price is $146.88, which gives an upside of 9.4%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $144.63 and $176.77.
Is The Procter & Gamble a dividend stock?
Yes, The Procter & Gamble is a dividend stock with a dividend yield of 2.88%. The latest dividend was $1.09 per share. The latest ex-dividend date (traded without the dividend) was 7/24/2026. The payout ratio is 62.3%, which is considered moderate. The next dividend payment is scheduled for 8/17/2026.
When does The Procter & Gamble pay a dividend in 2026?
The Procter & Gamble pays its next dividend on 8/17/2026. The latest dividend was $1.09 per share with an ex-dividend date of 7/24/2026. The dividend yield is 2.88%. The payout ratio of 62.3% points to moderate dividend coverage.
What is the risk of The Procter & Gamble stock?
The Procter & Gamble is rated as a stock with low risk. the annual standard deviation is 19.7%, which classifies the stock as low risk.
Is The Procter & Gamble overvalued?
The Procter & Gamble is considered fairly valued – the price is close to the analyst price target. The Procter & Gamble has the following valuation ratios: a P/E ratio of 22.2 (moderately to highly valued), a P/S ratio of 4.1, a P/B ratio of 6.5. The stock trades close to the analyst price target and is considered fairly valued.
Is The Procter & Gamble overbought?
No, The Procter & Gamble is not overbought. RSI is at 49.8 (neutral zone). The technical indicators show: RSI is at 49.8 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 0.0% below the 20-day average (short-term downtrend). In addition, MACD is negative with falling momentum (bearish).
When is the next The Procter & Gamble earnings report?
The date of the next earnings report for The Procter & Gamble has not been published yet. Check the company's investor calendar for updates.
Is The Procter & Gamble shorted?
The Procter & Gamble has minimal short interest of 0.99% of the free float, which is insignificant and points to very limited bearish sentiment.
Are insiders buying The Procter & Gamble stock?
No, insiders are not buying The Procter & Gamble shares – they are net sellers. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 110,986,861 $ sold. Active sellers include Ma. Fatima Francisco, Francisco Ma. Fatima, Whaley Susan Street and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is The Procter & Gamble a good stock?
Based on our total score, The Procter & Gamble is rated as a good stock with a total score of 61 out of 100. The stock scores above average on value, quality and momentum – it is among the top 39% in our database. The score is made up of Value: 47/100, Quality: 77/100, Momentum: 60/100. In addition: a dividend of 2.88%; technical signal: Hold. Whether The Procter & Gamble is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for The Procter & Gamble stock?
The outlook for The Procter & Gamble based on current data: the average analyst price target is $160.70 (+9.4%); the stock is in an uptrend (above SMA50 and SMA200); the P/E ratio is 22.2 (moderate). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is The Procter & Gamble stock moving?
The Procter & Gamble is stable right now. The technical indicators show: the price is close to the 20-day average; MACD is negative with falling momentum (bearish signal); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can The Procter & Gamble go?
The average analyst price target for The Procter & Gamble is $160.70, which corresponds to a potential gain of 9.4% from the current price of $146.88. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can The Procter & Gamble fall?
We lack enough history to give a specific floor for The Procter & Gamble. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does The Procter & Gamble do?
Procter & Gamble, eller P&G, er en kæmpe global spiller, der laver og sælger tonsvis af kendte mærkevarer til forbrugere. De tjener penge på fem hovedområder, som dækker alt fra skønhed til sundhedspleje. For eksempel har de mærker som Head & Shoulders og Olay i deres Beauty-s... The company belongs to the Defensivt forbrug sector, more specifically the Household & Personal Products industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate The Procter & Gamble as an investment.
Did The Procter & Gamble raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from The Procter & Gamble. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is The Procter & Gamble making money or losing money?
Yes, The Procter & Gamble is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 18.4% — which is solid. The operating margin (profit before interest and taxes) is 19.5%. At a P/E ratio of 22.2, you currently pay 22.2 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can The Procter & Gamble go bankrupt?
The bankruptcy risk of The Procter & Gamble is rated as low. Altman Z2 (a model for assessing financial distress) is 4.77 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 7 — which is strong. Debt relative to equity is 140% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does The Procter & Gamble have a lot of debt?
The Procter & Gamble has moderate debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 140%. For the defensivt forbrug sector, 80-150% counts as a typical level. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can The Procter & Gamble service its debt? Can service its debt without problems — the interest coverage ratio (how many times earnings can cover interest payments) is 6.2x, and net debt equals 1.1 years of earnings (EBITDA).
